For years, executives at Penumbra (Alameda, Calif.) avoided traditional venture capital funding. That decision allowed the company to have a much longer term view in developing technology to help stroke patients, said Adam Elsesser, chairman/CEO of Penumbra. Now the 11-year-old business, which develops devices that treat patients with neurological and vascular conditions, is making the move from a private company to a public one.